JP6096884B2 - 完全生物体マラリアワクチンのためのプラットフォームとしての齧歯類プラスモジウム寄生虫 - Google Patents

完全生物体マラリアワクチンのためのプラットフォームとしての齧歯類プラスモジウム寄生虫 Download PDF

Info

Publication number
JP6096884B2
JP6096884B2 JP2015506341A JP2015506341A JP6096884B2 JP 6096884 B2 JP6096884 B2 JP 6096884B2 JP 2015506341 A JP2015506341 A JP 2015506341A JP 2015506341 A JP2015506341 A JP 2015506341A JP 6096884 B2 JP6096884 B2 JP 6096884B2
Authority
JP
Japan
Prior art keywords
plasmodium
human
rodent
parasites
infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015506341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514745A (ja
Inventor
ピグナテッリ，ルイ ミゲル プルデンシオ
ピグナテッリ，ルイ ミゲル プルデンシオ
ダ モタ，マリア マニュエル ディアス
ダ モタ，マリア マニュエル ディアス
メンデス，アントニオ マニュエル バルベイロ
メンデス，アントニオ マニュエル バルベイロ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto de Medicina Molecular Joao Lobo Antunes
Original Assignee
Instituto de Medicina Molecular Joao Lobo Antunes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Medicina Molecular Joao Lobo Antunes filed Critical Instituto de Medicina Molecular Joao Lobo Antunes
Publication of JP2015514745A publication Critical patent/JP2015514745A/ja
Application granted granted Critical
Publication of JP6096884B2 publication Critical patent/JP6096884B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2015506341A 2012-04-17 2013-04-17 完全生物体マラリアワクチンのためのプラットフォームとしての齧歯類プラスモジウム寄生虫 Expired - Fee Related JP6096884B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT10626212 2012-04-17
PT106262 2012-04-17
PCT/IB2013/053050 WO2013156949A1 (en) 2012-04-17 2013-04-17 Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine

Publications (2)

Publication Number Publication Date
JP2015514745A JP2015514745A (ja) 2015-05-21
JP6096884B2 true JP6096884B2 (ja) 2017-03-15

Family

ID=48539330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015506341A Expired - Fee Related JP6096884B2 (ja) 2012-04-17 2013-04-17 完全生物体マラリアワクチンのためのプラットフォームとしての齧歯類プラスモジウム寄生虫

Country Status (10)

Country Link
US (1) US9655957B2 (enExample)
EP (1) EP2838554B1 (enExample)
JP (1) JP6096884B2 (enExample)
CN (1) CN104302313B (enExample)
AU (1) AU2013250814B2 (enExample)
BR (1) BR112014025823A8 (enExample)
IN (1) IN2014MN02275A (enExample)
PT (1) PT2838554T (enExample)
WO (1) WO2013156949A1 (enExample)
ZA (1) ZA201408440B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104771752B (zh) * 2015-04-21 2018-01-05 中国人民解放军第三军医大学 疟疾红内期灭活全虫疫苗的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0417762A8 (pt) * 2003-12-19 2015-12-22 Seattle Biomedical Res Institute Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2978048B1 (fr) * 2011-07-20 2014-10-10 Univ Paris Curie Composition vaccinale contre le paludisme

Also Published As

Publication number Publication date
WO2013156949A1 (en) 2013-10-24
AU2013250814A1 (en) 2014-12-04
HK1206243A1 (en) 2016-01-08
BR112014025823A2 (enExample) 2017-06-20
IN2014MN02275A (enExample) 2015-08-07
CN104302313B (zh) 2018-01-26
US20150071966A1 (en) 2015-03-12
PT2838554T (pt) 2018-11-23
JP2015514745A (ja) 2015-05-21
EP2838554B1 (en) 2018-08-22
CN104302313A (zh) 2015-01-21
BR112014025823A8 (pt) 2017-07-25
AU2013250814B2 (en) 2017-03-02
US9655957B2 (en) 2017-05-23
EP2838554A1 (en) 2015-02-25
ZA201408440B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
Goh et al. Vaccination with sporozoites: models and correlates of protection
Vaughan et al. Genetically engineered, attenuated whole-cell vaccine approaches for malaria
Zheng et al. Prospects for malaria vaccines: pre‐erythrocytic stages, blood stages, and transmission‐blocking stages
Matuschewski et al. Vaccines against malaria–an update
Hassert et al. Memory CD8+ T cell‐mediated protection against liver‐stage malaria
Mikolajczak et al. Preerythrocytic malaria vaccine development
White et al. Potential role of vaccines in elimination of Plasmodium vivax
CN103842029A (zh) 作为疫苗的hmgb2基因失活的减毒疟原虫
US11529404B2 (en) Doubly attenuated late liver stage malaria parasites and related compositions and methods
Richie High road, low road? Choices and challenges on the pathway to a malaria vaccine
JP2015514745A (ja) 完全生物体マラリアワクチンのためのプラットフォームとしての齧歯類プラスモジウム寄生虫
Sun et al. Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy
Serrano‐Coll et al. Plasmodium and Host Immunity: Evasion Strategies and Advances in Malaria Vaccination
Azab What do we know about the malaria vaccines?
HK1206243B (en) Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine
Rôla Comparative efficacy analysis of whole-sporozoite vaccines against Malaria
Manuel Rodent Plasmodium parasites as platforms for a whole-organism malaria vaccine
Reeder Vaccine Mediated Immunity To Malaria
Nicholas III Preliminary Characterization and Functional Validation of Pre-erythrocytic Vaccine Candidates for the Malaria Parasite Plasmodium vivax
Douradinha Immunization with mutant Plasmodium parasites: How is that achieved?
MUHAMMMAD et al. POTENTIAL ANTIGENTS FOR MALARIA VACCINE: A NEW HOPE FOR MALARIA ELIMINATION
McCaffery Development of Novel Immunogens for Malaria Vaccines and Serosurveillance
WO2024173724A2 (en) P36 and p52 as protective malaria vaccine antigens
Otarigho Malaria vaccine: hope in the future
Salman Assessment of novel liver-stage vaccines using transgenic rodent malaria parasites

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160725

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170216

R150 Certificate of patent or registration of utility model

Ref document number: 6096884

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees